Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the β2 subunit

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 1090-1103

  Marks, Michael J ^a   Whiteaker, Paul ^a   Calcaterra, Jennifer ^a   Stitzel, Jerry A ^a   Bullock, Amy E ^a   Grady, Sharon R ^a   Picciotto, Marina R ^a,b   Changeux, Jean Pierre ^a,c   Collins, Allan C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; HEXAMETHONIUM; NICOTINE; NICOTINE TARTRATE; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; RUBIDIUM;

ANIMAL TISSUE; BRAIN SYNAPTOSOME; CHOLINERGIC STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; BRAIN; BUNGAROTOXINS; DIHYDRO-BETA-ERYTHROIDINE; LIGANDS; MICE; MICE, INBRED BALB C; MUTATION; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; RUBIDIUM; RUBIDIUM RADIOISOTOPES; SYNAPTOSOMES;

EID: 0032937922     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Alkondon M and Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473.
2. Alkondon M and Albuquerque EX (1995) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J Pharmacol Exp Ther 271:494-506.
3. Alkondon M, Reinhardt S, Lorron C, Hermsen B, Maelicke A and Albuquerque EX (1994) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole-cell currents and identification of receptor subunits by in situ hybridization. J Pharmacol Exp Ther 271:494-506.
4. Brioni JD, Decker MW, Sullivan JP and Arneric SP (1997) The pharmacology of ( - )-nicotine and novel cholinergic channel activators. Adv Pharmacol 17:153-214.
5. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliot KJ and Johnson EC (1997) Pharmacological characterization of recombinant human neuronal acetylcholine receptors ha2β2, ha2β4, ha3β2, ha3β4, ha4β2, ha4β4, and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
6. 3H]dopamine release. Br J Pharmacol 117:595-606.
7. Conroy WG and Berg DK (1998) Nicotinic receptor subtypes in the developing chick brain: Appearance of a species containing the alpha4, beta2 and alpha5 gene products. Mol Pharmacol 53:392-401.
8. Corringer P-J, Bertrand S, Bohler S, Edelstein SJ, Changeux J-P and Bertrand D (1998) Critical elements determining diversity of agonist binding and desensitization of neuronal nicotinic acetylcholine receptors. J Neurosci 18:648-657.
9. Couturier S, Bertrand D, Matter J, Hernandez M, Bertrand S, Millar N, Valera S, Barkas T and Ballivet M (1990) A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homoligomeric channel blocked by α-bungarotoxin. Neuron 5:847-856.
10. Flores CM, Rogers SW, Pabreza LA, Wolfe BB and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
11. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S and Lindstrom J (1995) Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 48:774-782.
12. Goldman D, Deneris E, Luyten W, Kochhar A, Patrick J and Heinemann S (1987) Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell 48:965-973.
13. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP and Sullivan JP (1996) Stable expression, pharmacological properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J Pharmacol Exp Ther 276:289-297.
14. 3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856.
15. Gross A, Ballivet M, Rungger D and Bertrand D (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes: Role of the α subunit in agonist sensitivity and desensitization. Pfluegers Arch 410:545-551.
16. Harvey SC and Leutje CW (1996) Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits. J Neurosci 16:3798-3806.
17. Harvey SC, Maddox FN and Leutje CW (1996) Multiple determinants of dihydrobeta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits. J Neurochem 67:1953-1959.
18. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
19. Luetje CW and Patrick J (1991) Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845.
20. Lowry OH, Rosebrough NH, Farr AC and Randall RT (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
21. Lukas RJ (1989) Pharmacological distinctions between functional nicotinic acetylcholine receptors on PC12 rat pheochromocytoma and TE671 human medulloblastoma. J Pharmacol Exp Ther 251:175-182.
22. + efflux from mouse brain synaptosomes. J Pharmacol Exp Ther 274:833-841.
23. Marks MJ, Farnham DA, Grady SR and Collins AC (1993) Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther 264:542-552.
24. Marks MJ, Pauly JR, Gross SD, Deneris ED, Hermans-Borgmeyer I, Heinemann SF and Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784.
25. + efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther 277:1383-1396.
26. Marks MJ, Smith KW and Collins AC (1998) Differential agonist inhibition identifies multiple epibatine binding sites in mouse brain. J Pharmacol Exp Ther 285:377-386.
27. Marks MJ, Stitzel JA, Romm E, Wehner JM and Collins AC (1986) Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and α-bungarotoxin. Mol Pharmacol 30:427-436.
28. Mulle C, Vidal C, Benoit P and Changeux J-P (1991) Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J Neurosci 11:2588-2597.
29. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, LeNovere N, Vincent P, Merlo Pich E, Brulet P and Changeux J-P (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in brain. Nature (Lond) 374:65-67.
30. Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A and Role L (1996) Functional contributions of α5 subunit to neuronal acetylcholine receptor channels. Nature (Lond) 380:347-351.
31. Sacaan AI, Dunlop JL and Lloyd GK (1995) Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J Pharmacol Exp Ther 274:224-230.
32. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443.
33. Seguela P, Wadiche J, Dinely-Miller K, Dani J and Patrick J (1993) Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic channel highly permeable to calcium. J Neurosci 13:596-604.
34. Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M and Arneric SP (1996) A-85380 [3-(2-(S)-azetidinylmethoxypyridine]: In vitro pharmacological properties of a novel, high affinity alpha4 beta2 nicotinic acetylcholine receptor ligand. Neuropharmacology 35:725-734.
35. Wada E, McKinnon D, Heinemann S, Patrick J and Swanson LW (1990) The distribution of MRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (α5) in the rat central nervous system. Brain Res 526:45-53.
36. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J and Swanson LW (1989) Distribution of alpha-2, alpha-3, alpha-4 and beta-2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. J Comp Neurol 284:314-335.
37. Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K and Lindstrom J (1996) Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2 and beta4 subunits. J Biol Chem 271:17656-17665.
38. Whiting PJ and Lindstrom J (1988) Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J Neurosci 8:3395-3404.
39. Wonnacott S (1997) Presynaptic nicotinic Ach receptors. Trends Neurosci 20:92-98.
40. Yu ZJ, Morgan DG and Wecker L (1996) Distribution of three nicotinic receptor α4 mRNA transcripts in rat brain: Selective regulation by nicotine administration. J Neurochem 66:1326-1329.
41. Zoli M, Lena C, Picciotto MR and Changeux J-P (1998) Identification of four classes of nicotinic receptors using beta2 mutant mice. J Neurosci 18:4461-4472.